SI22285A - Tampon containing ph-regulating and antibacterially and antimicotically active formulation, and procedure of its manufacture - Google Patents
Tampon containing ph-regulating and antibacterially and antimicotically active formulation, and procedure of its manufacture Download PDFInfo
- Publication number
- SI22285A SI22285A SI200600138A SI200600138A SI22285A SI 22285 A SI22285 A SI 22285A SI 200600138 A SI200600138 A SI 200600138A SI 200600138 A SI200600138 A SI 200600138A SI 22285 A SI22285 A SI 22285A
- Authority
- SI
- Slovenia
- Prior art keywords
- chitosan
- formulation
- antibacterial
- tampons
- regulating
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title claims abstract description 91
- 239000000203 mixture Substances 0.000 title claims abstract description 91
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 32
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 96
- 239000000463 material Substances 0.000 claims abstract description 67
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 50
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 47
- 239000004310 lactic acid Substances 0.000 claims abstract description 45
- 210000001215 vagina Anatomy 0.000 claims abstract description 35
- 239000007858 starting material Substances 0.000 claims abstract description 32
- 150000007524 organic acids Chemical class 0.000 claims abstract description 30
- 208000032159 Vaginal inflammation Diseases 0.000 claims abstract description 5
- 201000008100 Vaginitis Diseases 0.000 claims abstract description 5
- 229920001661 Chitosan Polymers 0.000 claims description 118
- 239000000872 buffer Substances 0.000 claims description 37
- 230000000843 anti-fungal effect Effects 0.000 claims description 26
- 230000001857 anti-mycotic effect Effects 0.000 claims description 22
- 230000001105 regulatory effect Effects 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 11
- 239000007921 spray Substances 0.000 claims description 11
- 230000004054 inflammatory process Effects 0.000 claims description 10
- 206010061218 Inflammation Diseases 0.000 claims description 9
- 230000002378 acidificating effect Effects 0.000 claims description 9
- 239000000835 fiber Substances 0.000 claims description 8
- 229920000297 Rayon Polymers 0.000 claims description 6
- 230000002745 absorbent Effects 0.000 claims description 6
- 239000002250 absorbent Substances 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 5
- 239000011345 viscous material Substances 0.000 claims description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 3
- 241000191967 Staphylococcus aureus Species 0.000 claims description 3
- 206010046543 Urinary incontinence Diseases 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 230000003449 preventive effect Effects 0.000 claims description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- 229920000433 Lyocell Polymers 0.000 claims description 2
- 206010041925 Staphylococcal infections Diseases 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 2
- 239000004327 boric acid Substances 0.000 claims description 2
- 238000009109 curative therapy Methods 0.000 claims description 2
- 230000002538 fungal effect Effects 0.000 claims description 2
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 2
- 239000004626 polylactic acid Substances 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 50
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 206010046914 Vaginal infection Diseases 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- -1 cationic polysaccharides Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000037125 natural defense Effects 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000006179 pH buffering agent Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010063057 Cystitis noninfective Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 208000037009 Vaginitis bacterial Diseases 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 239000000522 vaginal cream Substances 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 239000000029 vaginal gel Substances 0.000 description 1
- 229940044950 vaginal gel Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2002—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use
- A61F13/202—Catamenial tampons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2074—Tampons, e.g. catamenial tampons; Accessories therefor impregnated with hydrophobic, hydrophilic, skin enhancers, medicinal etc. substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2082—Apparatus or processes of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Dermatology (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Predloženi izum se nanaša na tampon, ki vsebuje pH regulirajočo ter antibakterijsko in antimikotično aktivno formulacijo, in ki ima v vagini sposobnost vzdrževati njeno primemo vlažnost in njen fiziološki pH, hkrati pa ima tudi antibakterijsko in antimikotično delovanje. Tampon v smislu izuma vsebuje vhodni material za izdelavo tamponov, na katerega je nanesena formulacija, ki je raztopina hitozana in/ali hitozanskega materiala v razredčeni organski kislini ali njenem derivatu, prednostno mlečni kislini. Predloženi izum se nanaša tudi na postopek za izdelavo takega tampona in na njegovo uporabo pri preprečevanju in/ali zdravljenju vaginalnih vnetij.The present invention relates to a tampon containing a pH regulating and antibacterial and antimycotic active formulation, which has the ability to maintain its humidity and its physiological pH in the vagina, while having an antibacterial and antimycotic action. The tampon of the invention comprises a starting material for the manufacture of tampons, to which a formulation is applied which is a solution of chitosan and / or chitosan material in dilute organic acid or a derivative thereof, preferably lactic acid. The present invention also relates to a process for the manufacture of such a tampon and to its use in the prevention and / or treatment of vaginal inflammation.
Tehnični problem in stanje tehnikeTechnical problem and state of the art
V zadnjem času opažamo, da sodoben način življenja in nekateri modni trendi, kot je način oblačenja, vodita v večjo uporabo nožničnih tamponov. Njihova uporaba tako danes ni vezana zgolj na čas menstruacije, temveč jih ženske uporabljajo čez cel ciklus in to kot zaščito pred fiziološkimi ali patološkimi izcedki iz vagine. Pri tovrstni uporabi pogosto prihaja do nevšečnosti, kot so npr. pogostejši pojav in ponovitve vnetja vagine. Klinične izkušnje kažejo, da so vaginalni izcedki in vnetja glavni razlog za obiske v ginekološki ambulanti. Vnetje nožnice spremlja izcedek, ki ga ženske pogostokrat skušajo odpraviti s spiranjem z vodo, kar pa še dodatno zmanjša kislost nožnice.Recently, we have noticed that the modern way of life and some fashion trends, such as the way of dressing, lead to more use of vaginal tampons. Today, their use is not only related to the period of menstruation, but is used by women throughout the cycle as a protection against physiological or pathological discharge from the vagina. This type of use often causes inconvenience, such as more frequent occurrence and recurrence of inflammation of the vagina. Clinical experience shows that vaginal discharge and inflammation are the main reason for visits to the gynecological outpatient clinic. Inflammation of the vagina is accompanied by a discharge that women often try to eliminate by washing with water, which further reduces the acidity of the vagina.
Pod vplivom estrogenov se pri ženskah v reproduktivni dobi v vaginalnem epiteliju kopiči glikogen. Anaerobni metabolizem glikogena v epitelnih celicah in predvsem njegova razgradnja s strani vaginalne flore sta vzrok za nizko vrednost pH v nožnici, ki pri večini žensk znaša med 3,6 in 4,5 [Boskey ER, Telsch KM, Whaley KJ,Under the influence of estrogens, glycogen accumulates in women of reproductive age in the vaginal epithelium. Anaerobic glycogen metabolism in epithelial cells and, above all, its degradation by the vaginal flora are the cause of the low pH in the vagina, which is between 3.6 and 4.5 in most women [Boskey ER, Telsch KM, Whaley KJ,
Moench TR, Cone RA. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun. 1999; 67: 5170-5]. To rahlo kislo stanje v nožnici zagotavlja učinkovito oviro proti rasti patogenih mikroorganizmov, ki se jih običajno povezuje z vaginalno infekcijo, saj takšni mikroorganizmi ne rastejo pod pH okoli 5.Moench TR, Cone RA. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun. 1999; 67: 5170-5]. This slightly acidic condition in the vagina provides an effective barrier to the growth of pathogenic microorganisms, which is usually associated with vaginal infection, since such microorganisms do not grow below pH 5.
Pri vnetju nožnice, bakterijski vaginozi, pH narašča, zaradi česar upada število laktobacilov, s tem se zmanjšuje naravna obramba vagine in se posledično neovirano razraščajo različne bakterije [Tomas MS, Bru E, Nader-Macias ME. Comparison of the growth and hydrogen peroxide production by vaginal probiotic lactobacilli under different culture conditions. Am J Obstet Gynecol 2003; 188: 35-44]. Podobno spremembo v kislosti vagine in njeno posledično vnetje lahko povzroči tudi pogosta uporaba tamponov.In vaginal inflammation, bacterial vaginosis, the pH rises, causing a decrease in lactobacilli counts, thus reducing the natural defense of the vagina and, as a consequence, the various bacteria grow freely [Tomas MS, Bru E, Nader-Macias ME. Comparison of growth and hydrogen peroxide production by vaginal probiotic lactobacilli under different culture conditions. Am J Obstet Gynecol 2003; 188: 35-44]. A similar change in the acidity of the vagina and its subsequent inflammation can also be caused by the frequent use of tampons.
Znano je tudi, da predstavlja infekcija vagine in zunanjega spolovila enega izmed dejavnikov tveganja za okužbo mehurja, ki je pri starejših ženskah eden izmed glavnih vzrokov za uhajanje vode (t.i. urinsko inkontinenco).It is also known that infection of the vagina and external genitalia is one of the risk factors for bladder infection, which is one of the main causes of water leakage (so called urinary incontinence) in older women.
Za premagovanje problema zmanjšanja v kislosti vagine in za ponovno vzpostavitev želenega normalnega kislega stanja ter želene vaginalne flore so bile v preteklosti razvite številne formulacije in tehnike. Takšni napori so vključevali razvoj formualcij, kot so npr. raztopine, geli, svečke, vaginalete in podobno, ki se vstavijo v vagino v njihovi pripravljeni obliki. Vendar pa imajo ti tipi formulacij skih oblik pomanjkljivosti z vidika praktičnosti in sprejemljivosti. Tako lahko npr. vaginalete, ki vsebujejo med drugim kombinacijo mlečne kisline in hitozana, ob sproščanju učinkovine oz. raztapljanju neposredno na sluznico, povzročijo preveliko lokalno koncentracijo oz. kislost, kar je lahko neprijetno za uporabnice.Many formulations and techniques have been developed in the past to overcome the problem of reduction in vaginal acidity and to restore the desired normal acidic state and the desired vaginal flora. Such efforts have included the development of formulations such as solutions, gels, suppositories, vaginals and the like, which are inserted into the vagina in their prepared form. However, these types of formulations have drawbacks in terms of practicality and acceptability. Thus, e.g. vaginaletes containing, inter alia, a combination of lactic acid and chitosan while releasing the active substance or dissolving directly into the mucous membranes cause excessive local concentration or acidity, which can be uncomfortable for users.
Iz literature je znano, da hitozan lahko izkazuje antibakterijske in antimikotične lastnosti. Hitozan predstavlja naravno protimikrobno sredstvo, ki ga uporabljajo tako v prehrambeni industriji za preventivo pred razraščanjem bakterij in glivic v hrani, kot tudi v farmacevtski industriji, kjer ga npr. dodajajo različnim mediciranim vaginalnim kremam. Znano je, da hitozan zmanjšuje aktivnost glivice Candida albicans, ki je možni povzročitelj nožnične kandidoze, in bakterije Staphylococcus aureus, ki je možni povzročitelj sindroma toksičnega šoka. Njegova uporaba je vama tudi v nosečnosti, dodatek hitozana npr. v vaginalnem gelu pomaga namreč vzdrževati primeren pH v vagini, kar naj bi pomenilo preventivo pred nastankom predčasnega poroda.It is known from the literature that chitosan can exhibit antibacterial and antifungal properties. Chitosan is a natural antimicrobial agent used both in the food industry to prevent the growth of bacteria and fungi in food, as well as in the pharmaceutical industry, where, for example, chitosan. they add to various medicated vaginal creams. Chitosan is known to reduce the activity of Candida albicans, a potential cause of vaginal candidiasis, and Staphylococcus aureus, a potential cause of toxic shock syndrome. It is also used during pregnancy, for example chitosan supplementation. in the vaginal gel, it helps to maintain a proper pH in the vagina, which is supposed to be a prevention against the birth.
Mlečna kislina nastaja s pomočjo mlečnokislinskih bakterij, ki se nahajajo v zdravem okolju vaginalne flore in je pomembna za naravno obrambo pred okužbami in vnetji. Kislo okolje vagine pH 3,85-4,00 vzpodbudi razmnoževanje mlečnokislinskih bakterij, ki so sposobne razmnoževanja in preživetja le v tem pH okolju. Povečano število mlečnokislinskih bakterij izpodrine ostale bakterije in varuje telo pred vdorom škodljivih bakterij, ki povzročajo razne neprijetne okužbe in vnetja. V vagini ohranjajo naravni kisli ekosistem v območju pH 3,85 - 4,00.Lactic acid is produced by lactic acid bacteria, which are found in the healthy environment of the vaginal flora and are important for natural defense against infection and inflammation. The acidic environment of the vagina pH 3.85-4.00 promotes the reproduction of lactic acid bacteria that are capable of reproduction and survival only in this pH environment. The increased number of lactic acid bacteria displaces other bacteria and protects the body from invading harmful bacteria that cause various unpleasant infections and inflammations. The vagina maintains the natural acidic ecosystem in the pH range 3.85 - 4.00.
V US 6,710,220 B2 je opisana pH zniževalna formulacija in tamponi, ki vsebujejo formulacijo za namen zniževanja pH vagine. Navedena formulacija vsebuje polimer organske kisline (npr. polimer mlečne kisline), trdno organsko kislino in omakalno sredstvo. Ta formulacija se nanaša iz raztopine acetona na ustrezen tamponski trak, dokument pa obravnava predvsem uporabo tampona še zlasti v času menstruacije.US 6,710,220 B2 describes a pH lowering formulation and tampons containing a formulation for the purpose of lowering the pH of the vagina. That formulation contains an organic acid polymer (e.g. lactic acid polymer), a solid organic acid and a wetting agent. This formulation applies from a solution of acetone to a suitable buffer strip, and the document addresses in particular the use of the buffer especially during menstruation.
US 2005/0124799 Al opisuje izum, ki se nanaša na izdelke, kot so absorpcijski izdelki za enkratno uporabo, ki vsebujejo kationske polisaharide, prednostno hitozanske materiale skupaj s kislimi pH puferskimi sredstvi. Ta dokument obravnava kombinacijo hitozana s kislimi pH puferskimi sredstvi za preprečevanje neprijetnega vonja, ki nastane ob uporabi takih izdelkov, še zlasti higienskih podlog, ki so sestavljene iz več različnih komponent oz. večih različno obdelanih plasti.US 2005/0124799 A1 describes an invention which relates to products such as disposable absorbent products containing cationic polysaccharides, preferably chitosan materials together with acidic pH buffering agents. This document discusses the combination of chitosan with acidic pH buffering agents to prevent odors resulting from the use of such products, in particular hygienic substrates consisting of several different components. of several differently treated layers.
V patentni prijavi CN 1365833 je omenjen postopek za pripravo absorpcijskega izdelka, na katerega je naprsen hitozan raztopljen v razredčeni kislini, pri čemer je izdelek namenjen preprečevanju preležanin oziroma z njimi povezanih neželenih pojavov na koži.The patent application CN 1365833 mentions a process for the preparation of an absorbent product to which chitosan is dissolved in dilute acid, the product being intended to prevent bedding or related side effects on the skin.
Podroben opis izumaDETAILED DESCRIPTION OF THE INVENTION
Z namenom rešiti zgoraj navedene probleme in ob upoštevanju dejstva, da na množičnost oz. pogostost uporabe tamponov ne moremo vplivati, je bil namen predloženega izuma razviti nove izboljšane tampone, katerih uporaba ne bi imela uvodoma navedenih opaženih negativnih učinkov, npr. povečanega tveganja za pojav vnetja in ki bi ob pogosti uporabi vzdrževali primemo vlažnost vagine in vzdrževali in/ali ustvarjali v vagini njen fiziološki pH, hkrati pa bi imeli antibakterijsko in antimikotično delovanje. Predmet predloženega izuma je torej tampon, ki vsebuje pH regulirajočo ter antibakterijsko in antimikotično aktivno formulacijo, in ki ima ob uporabi v vagini naslednje napredne in nove lastnosti: znižuje in/ali vzdržuje pH vagine na fiziološkem pH, vzdržuje ustrezno vlažnost vagine in ima antibakterijsko in antimikotično delovanje.In order to solve the above problems and taking into account the fact that on the mass or. the frequency of the use of tampons cannot be affected, the purpose of the present invention was to develop new improved tampons, the use of which would not have the negative effects mentioned above, e.g. increased risk of inflammation and which, when used frequently, would maintain the vagina's humidity and maintain and / or create a physiological pH within the vagina, while having antibacterial and antifungal effects. The subject of the present invention is therefore a tampon containing a pH regulating and antibacterial and antifungal active formulation, which, when used in the vagina, has the following advanced and novel properties: lowers and / or maintains the pH of the vagina at physiological pH, maintains the proper humidity of the vagina and has antibacterial and antifungal action.
Kljub številnim ločenim aplikacijam hitozana ali hitozanskih materialov in organskih kislin, kot npr. mlečne kisline, na celulozni material, do sedaj po našem vedenju še nihče ni metodično proučil in izvedel hkratne aplikacije obeh komponent, hitozana in/ali hitozanskega materiala in ustrezne organske kisline ali njenega derivata, prednostno mlečne kisline ali njenih derivatov, na vhodni material, ki je primeren za izdelavo tamponov, in ki v tamponu predstavlja absorpcijsko plast oz. komponento, z namenom izdelati tampone v smislu izuma, pri čemer bi bile izpolnjene in usklajene:Despite numerous separate applications of chitosan or chitosan materials and organic acids, such as e.g. So far, to our knowledge, no lactic acid, on cellulosic material, has been methodically studied and performed simultaneously by the simultaneous application of both components, chitosan and / or chitosan material, and the corresponding organic acid or its derivative, preferably lactic acid or its derivatives, to input material which is suitable for the manufacture of tampons, and which in the tampon represents the absorption layer or. a component for the purpose of producing tampons according to the invention, with the following being fulfilled and harmonized:
tehnične zahteve pri nanosu raztopine hitozana in/ali hitozanskega materiala v ustrezni organski kislini ali njenem derivatu, prednostno mlečni kislini ali njenem derivatu, na vhodni material, primeren za izdelavo tamponov, in sicer tudi s tehniko pršenja, zahteve po takšni kombinaciji učinkovin oz. po takšni raztopini hitozana in/ali hitozanskega materiala v ustrezni organski kislini, prednostno mlečni kislini, ali njenem derivatu, da bo po fazi nanosa na vhodni material omogočila tehnološko in ekološko neproblematično izdelavo tampona na stroju za izdelavo tampona, in zahteva izdelati končni izdelek, tampon, ki bo ustrezal predpisanim tehnološkim standardom in ki bo zniževal in/ali vzdrževal pH vagine na njenem fiziološkem pH, vzdrževal ustrezno vlažnost vagine ter imel antibakterijsko in antimikotično delovanje.technical requirements for the application of a solution of chitosan and / or chitosan material in a suitable organic acid or derivative thereof, preferably lactic acid or a derivative thereof, to a starting material suitable for the manufacture of tampons, also by means of a spray technique; after such a solution of chitosan and / or chitosan material in a suitable organic acid, preferably lactic acid, or a derivative thereof, that after the phase of application to the starting material will allow for the technological and ecologically sound production of the tampon on the tampon machine, and requires the production of the final product, the tampon , which will meet the prescribed technological standards and which will lower and / or maintain the pH of the vagina at its physiological pH, maintain adequate vaginal humidity and have antibacterial and antifungal action.
Z namenom izdelati nov izboljšan in modificiran tampon v smislu izuma in ob upoštevanju zgoraj navedenih zahtev, smo razvili in optimizirali formulacijo za nanos na vhodni material za izdelavo tamponov, kije raztopina hitozana in/ali hitozanskega materiala v organski kislini ali njenem derivatu in ki ima naslednje značilnosti:In order to produce a new improved and modified tampon according to the invention and in accordance with the above requirements, we have developed and optimized a formulation for application to a starting material for the manufacture of tampons, which is a solution of chitosan and / or chitosan material in an organic acid or a derivative thereof, having the following Features:
- hitozan in/ali hitozanski material izkazuje antibakterijske in antimikotične lastnosti, prednostno pa je v formulaciji prisoten v koncentraciji višji od 0,5 mas.%;- the chitosan and / or chitosan material exhibits antibacterial and antifungal properties, and is preferably present in the formulation at a concentration higher than 0.5% by weight;
- hitozan in/ali hitozanski material je v formulaciji popolnoma topen (slaba stran npr. hitozana je, daje alkalen in netopen v vodnem mediju, topen je samo v kislem mediju specifičnih kislin);- the chitosan and / or chitosan material is completely soluble in the formulation (the downside, eg chitosan, is alkaline and insoluble in aqueous medium, soluble only in the acidic medium of specific acids);
- pH raztopine je tak, da ustreza fiziološkemu pH vagine, prednostno pa je pH v območju 3,6-4,4; in- the pH of the solution is appropriate to the physiological pH of the vagina, and preferably the pH is in the range 3.6-4.4; and
- ima takšno viskoznost, ki omogoča nanašanje raztopine na vhodni material za izdelavo tamponov, prednostno s tehniko pršenja;- has a viscosity that allows the solution to be applied to the input material for the production of tampons, preferably by spray technique;
pri čemer ta formulacija hkrati omogoča, dawhereby this formulation simultaneously enables
- sta količina nanesene formulacije in oblika nanosa takšna, da se nanesena formulacija dobro absorbira v vhodni material za izdelavo tamponov;- the amount of the formulation applied and the form of application are such that the applied formulation is well absorbed into the input material for the manufacture of tampons;
- je tako obdelan vhodni material za tampone možno oblikovati na stroju za izdelavo tamponov v končni izdelek, tampon, ki ustreza v stroki predpisanim standardom, in- the tampon input material thus treated can be molded on a tampon machine into a finished product, a tampon that meets the standards prescribed in the art, and
- je nanesena količina učinkovin, še zlasti prednostno hitozana in mlečne kisline, takšna, da ima tampon ob uporabi v vagini naslednje želene lastnosti: ima sposobnost vzdrževati ustrezno vlažnost vagine, ima sposobnost zniževati in/ali vzdrževati pH vagine na fiziološkem pH in ima antibakterijsko in antimikotično aktivnost.- the quantity of active ingredients, especially preferably chitosan and lactic acid, is such that the tampon has the following desired properties when used in the vagina: it has the ability to maintain adequate vaginal humidity, has the ability to lower and / or maintain the pH of the vagina at physiological pH and is antibacterial, and antifungal activity.
Formulacija za uporabo v smislu izuma jev obliki raztopine, pripravljene iz hitozana in/ali hitozanskega materiala in ustrezne organske kisline ali njenega derivata, pri čemer sta lahko hitozan in/ali hitozanski material in organska kislina ali njen derivat v kakršnemkoli takšnem molamem razmeiju, ki daje formulaciji tu predhodno navedene značilnosti.A formulation for use according to the invention in the form of a solution prepared from chitosan and / or chitosan material and the corresponding organic acid or derivative thereof, wherein chitosan and / or chitosan material and organic acid or a derivative thereof may be in any such molar ratio giving the formulation of the characteristics listed above.
Ustrezna organska kislina za uporabo v formulaciji v smislu izuma je lahko mlečna kislina, polimlečna kislina, citronska kislina ali borova kislina. Kot derivate organske kisline lahko uporabimo npr. derivate mlečne kisline, kot je katerikoli kisli laktat. V smislu izuma je prednostna uporaba razredčene mlečne kisline. Še zlasti je za pripravo formulacije primerna uporaba od 3 % do 20 % raztopine mlečne kisline, glede na omejitve z vidika zahteve po fiziološkem pH in končne viskoznosti formulacije, pa je v smislu izuma še posebno prednostna uporaba okoli 5 % raztopine mlečne kisline.Suitable organic acid for use in the formulation of the invention may be lactic acid, polylactic acid, citric acid or boric acid. Organic acid derivatives can be used, e.g. lactic acid derivatives such as any acidic lactate. The use of dilute lactic acid is preferred in the invention. In particular, the use of from 3% to 20% lactic acid solution is suitable for the preparation of the formulation, and in view of the limitations of the physiological pH requirement and the final viscosity of the formulation, the use of about 5% lactic acid solution is particularly preferred in the invention.
Kot hitozan, ki je primeren za uporabo v formulaciji v smislu izuma, je primeren v vodi netopen hitozan, bodisi hitozan z nizko ali visoko povprečno molekulsko maso. Kot hitozanski materiali oz. derivati hitozana so primerni npr. sulfoniran hitozan (delno) in karboksimetiliran hitozan. Še posebno prednostna je uporaba hitozana z nizko povprečno molekulsko maso.Chitosan suitable for use in the formulation of the invention is water-insoluble chitosan, whether chitosan with low or high average molecular weight. Like chitosan materials or. chitosan derivatives are suitable e.g. sulfonated chitosan (partially) and carboxymethylated chitosan. Particularly preferred is the use of chitosan with a low average molecular weight.
Znano je, da imajo raztopine hitozana s koncentracijo enako ali višjo od 0,5 mas.% hitozana antibakterijske in antimikotične lastnosti, še primerna maksimalna gornja koncentracija raztopine hitozana s stališča njene viskoznosti in s tem uporabnosti za nanos s tehniko pršenja, pa je okoli 2 mas. %.Chitosan solutions with a concentration equal to or greater than 0.5% by weight of chitosan are known to have antibacterial and antifungal properties, and a maximum maximum upper concentration of chitosan solution from the point of view of its viscosity and thus useful for application by the spray technique, is about 2 wt. %.
V prednostni izvedbi izuma je formulacija za nanos na vhodni material za tampone 0,5-2,0 % raztopina hitozana in/ali hitozanskega materiala, (preračunano na koncentracijo v formulaciji), v razredčeni organski kislini ali njenem derivatu, pri čemer se za pripravo formulacije uporabi 3-20 % raztopina organske kisline ali njenega derivata.In a preferred embodiment of the invention, the formulation for application to the tampon starting material is a 0.5-2.0% solution of chitosan and / or chitosan material (calculated on the concentration in the formulation), in dilute organic acid or a derivative thereof, to be prepared formulations use a 3-20% organic acid solution or derivative thereof.
V smislu izuma je še posebno primerna formulacija v obliki 0,5-2,0 % raztopine hitozana in/ali hitozanskega materiala (preračunano na koncentracijo v formulaciji) v mlečni kislini, pri čemer se formulacija pripravi tako, da se v vodno suspenzijo hitozana in/ali hitozanskega dodaja 3 %-20 % raztopina mlečne kisline, še zlasti prednostno 5 % mlečne kisline, do popolne topnosti ob segrevanju (na okoli 40°C).According to the invention, a formulation in the form of 0.5-2.0% solution of chitosan and / or chitosan material (recalculated to the concentration in the formulation) in lactic acid is particularly suitable, the formulation being prepared by pouring into the aqueous suspension of chitosan and / or chitosan adds 3% -20% lactic acid solution, especially preferably 5% lactic acid, to complete solubility when heated (to about 40 ° C).
Po še bolj prednostni izvedbi izuma je formulacija za nanos na vhodni material za tampone raztopina hitozana v mlečni kislini, ki vsebuje, preračunano na končno koncentracijo obeh komponent v raztopini, 0,8-1,2 mas.% hitozana v 0,8-1,2 % raztopini mlečne kisline, še zlasti pa okoli 1 % hitozana v okoli 1 % raztopini mlečne kisline. Še posebno prednostna je raztopina, ki vsebuje hitozan z nizko povprečno molekulsko maso.According to a still more preferred embodiment of the invention, the formulation for application to the tampon starting material is a solution of chitosan in lactic acid, containing, calculated on the final concentration of the two components in the solution, 0.8-1.2% by weight of chitosan in 0.8-1 , 2% lactic acid solution, and in particular about 1% chitosan in about 1% lactic acid solution. Particularly preferred is a solution containing chitosan with a low average molecular weight.
Naj večja še primerna viskoznost formulacije v smislu izuma je takšna, ki omogoča njeno naprševanje na vhodni material. Viskoznost raztopine lahko sega od 1 do 1000 mPa.s pri 25 °C, prednostna viskoznost formulacije pa območju 200-800 mPa.s.The highest suitable viscosity of the formulation of the invention is such that it can be sprayed onto the starting material. The viscosity of the solution can range from 1 to 1000 mPa.s at 25 ° C, and the preferred viscosity of the formulation ranges from 200-800 mPa.s.
Primerni vhodni materiali za izdelavo tamponov oz. njihove absorpcijske komponente so celulozni materiali, kot npr. bombaž, viskoza, modal ali liocel, in celulozni materiali obdelani s karboksimetil celulozo (CMC), kot npr. bombaž obdelan s CMC ali viskoza obdelana s CMC. Še posebno prednostna je uporaba viskoznega materiala.Suitable input materials for the production of tampons or. their absorption components are cellulosic materials such as e.g. cotton, viscose, modal or lyocell, and carboxymethyl cellulose (CMC) treated cellulosic materials such as e.g. CMC treated cotton or CMC viscose. Particularly preferred is the use of viscous material.
Vhodni material za izdelavo tamponov, na katerega se nanaša raztopina v smislu izuma, je prednostno v obliki traku.The starting material for making tampons to which the solution of the invention relates is preferably in the form of a strip.
Nadalje so kot vhodni materiali za izdelavo tamponov lahko primerni tudi drugi polimerni materiali, ki se jih da obdelovati kot vlakna, in ki omogočajo ustrezno absorpcijo in reverzibilno/ireverzibilno vezavo učinkovin v smislu izuma na vhodni material, na katerega je napršena formulacija.Furthermore, other polymeric materials which can be treated as fibers may be suitable as starting materials for the production of tampons, allowing for the proper absorption and reversible / irreversible binding of the active ingredients of the invention to the starting material to which the formulation is sprayed.
Tampon, kije predmet predloženega izuma, ima absorpcijsko komponento izdelano iz vhodnega materiala za tampone, prednostno celuloznega materiala, še zlasti viskoznega materiala, na katerega je nanesena formulacija v smislu izuma, pri čemer je formulacija 0,5-2,0 % raztopina hitozana in/ali hitozanskega materiala, (preračunano na končno koncentracijo v formulaciji), v razredčeni organski kislini ali njenem derivatu, prednostno mlečni kislini, pri čemer se za pripravo formulacije uporabi 3-20 % raztopina organske kisline in/ali njenega derivata.The tampon of the present invention has an absorbent component made from a starting material for tampons, preferably a cellulosic material, in particular a viscous material to which the formulation of the invention is applied, wherein the formulation is 0.5-2.0% chitosan solution and / or chitosan material (converted to the final concentration in the formulation), in dilute organic acid or a derivative thereof, preferably lactic acid, using a 3-20% organic acid solution and / or derivative thereof to prepare the formulation.
Po prednostni izvedbi vsebuje tampon vhodni material za tampone, na katerega je nanesena formulacija, ki vsebuje, preračunano na končno koncentracijo v formulaciji, 0,8-1,2 mas.% hitozana v 0,8-1,2 % raztopini mlečne kisline. Še zlasti je prednosten tampon, ki vsebuje vhodni material za izdelavo tamponov, na katerega je bila nanesena formulacija, ki vsebuje, preračunano na končno koncentracijo v raztopini, okoli 1 mas.% hitozana v okoli 1 % raztopini mlečne kisline.According to a preferred embodiment, the tampon contains a tampon starting material, to which a formulation containing from 0.8 to 1.2% by weight of chitosan in a 0.8-1.2% solution of lactic acid is applied, calculated to the final concentration in the formulation. Particularly preferred is a tampon containing a starting material for the manufacture of tampons, to which a formulation comprising, based on the final concentration in solution, about 1% by weight of chitosan in about 1% lactic acid solution has been applied.
Po prednostni izvedbi formulacijo nanesemo na vhodni material za izdelavo tamponov s tehniko pršenja. Formulacija zaradi svojih lastnosti omogoča njeno enakomerno, homogeno in konstantno naprševanje na vhodni material. Dobro se vpije v vhodni material, tako da se na površini materiala ne ustvari neželen lepljiv sloj, ki bi se lahko odlagal na tiste vrtljive dele stroja za izdelavo tamponov, ki prihajajo v stik s tamponskim trakom. Tehnika naprševanja je ugodna tako iz ekološkega in tehnološkega, kot tudi ekonomskega vidika, saj pri njej ni odpadne raztopine, kot npr. pri tehniki nanašanja učinkovin s tehniko potapljanja v kopel, kjer se kopel izčrpava in jo je potrebno menjavati, kar ima za posledico odpadno raztopino. Tehnika naprševanja, za razliko od npr. tehnike potapljanja, omogoča, da se na material za tampone nanese le toliko raztopine, kot jo je dejansko potrebno za izdelavo končnega izdelka z želenimi pH-regulirajočimi ter antibakterijskimi in antimikotičnimi lastnostmi, in sicer v kar se da natančno predhodno določeni in izbrani količini. Pri postopku pršenja ni odpadne raztopine, uporabljena vodna raztopina oz. formulacija v smislu izuma pa tudi ne vsebuje nobenih dodatnih za okolje obremenilnih snovi, ki bi bile problematične tako s tehnološkega kot tudi ekološkega vidika.According to a preferred embodiment, the formulation is applied to the input material for the production of tampons using a spray technique. Due to its properties, the formulation enables its uniform, homogeneous and constant spray on the input material. It is well absorbed into the input material so that no unwanted adhesive layer is formed on the surface of the material, which can be deposited on those rotating parts of the tampon machine that come in contact with the buffer strip. The spraying technique is advantageous both ecologically, technologically as well as economically, since it does not contain waste solution, such as for example. in the technique of substance application by the technique of immersion in the bath, where the bath is exhausted and needs to be replaced, resulting in a waste solution. Spraying technique, unlike e.g. Diving techniques allow only a solution to be applied to the tampon material as is actually needed to produce the final product with the desired pH-regulating and antibacterial and antifungal properties, in as precise a predetermined and selected quantity as possible. There is no waste solution in the spraying process, the aqueous solution used or. the formulation of the invention also does not contain any environmentally hazardous substances that are problematic from a technological as well as an ecological point of view.
Razvili smo postopek izdelave novega tampona s pH regulirajočimi ter antibakterijskimi in antimikotičnimi lastnostmi, katerega izdelava ne zahteva dodatnih investicij na že obstoječem stroju za izdelavo tamponov zaradi dodatnih zahtev, ki bi bile posledica nanosa formulacije na vhodni material, kot npr. dodatne opreme za sušenje na stroju za izdelavo tamponov, dodatnih varnostnih in ekoloških zahtev zaradi uporabe npr. kakšnega specifičnega topila v formulaciji itd.We have developed a process for the production of a new buffer with pH regulating and antibacterial and antimycotic properties, the production of which does not require additional investment on the existing tampon making machine due to the additional requirements that would result from the application of the formulation to the starting material, such as. additional drying equipment on the tampon making machine, additional safety and environmental requirements due to the use of e.g. what specific solvent in the formulation, etc.
Opisana formulacija omogoča kontinuiran postopek izdelave tampona v smislu izuma, pri katerem se formulacija nanaša, prednostno s tehniko pršenja, na material za izdelavo tamponov, prednostno viskozni tamponski trak, neposredno pred vstopom letega v stroj za izdelavo tamponov, čemur sledi vstop s formulacijo obdelanega vhodnega materiala za izdelavo tamponov v stroj za izdelavo tamponov in izdelava tampona.The described formulation provides a continuous process for the manufacture of a tampon according to the invention, wherein the formulation relates, preferably by spray technique, to a tampon fabric material, preferably a viscous tampon strip, immediately prior to entry of a fly into a tampon machine, followed by entry with a treated inlet formulation material for making tampons into a tampon making machine and making tampons.
V nadaljnji izvedbeni varianti tega izuma je možno formulacijo v smislu izuma nanašati oz. naprševati na vhodni material za izdelavo tamponov v postopku izdelave tamponskega traku, ki poteka ločeno od postopka izdelave tamponov. Iz tako obdelanega vhodnega materiala, prednostno viskoznega tamponskega traku, nato na ločenem stroju za izdelavo tamponov izdelamo tampon.In a further embodiment of the present invention, the formulation of the invention may be applied or administered. spray on the input material for the production of tampons in the process of making the buffer strip, which is separate from the process of making tampons. From the input material thus treated, preferably a viscous tampon tape, a tampon is then produced on a separate tampon machine.
Tipični, a ne omejujoči primeri tamponov v smislu izuma so tamponi, ki imajo absorpcijsko komponento oz. plast izdelano iz vhodnega materiala za izdelavo tamponov v obliki 20-25 cm dolgega in 4-6 cm širokega viskoznega tamponskega traku z maso viskoznih vlaken 2-4 g, na katerega je bilo pred vstopom v stroj za izdelavo tamponov naneseno s tehniko pršenja 0,2-0,5 g formulacije, ki vsebuje, preračunano na končno koncentracijo v formulaciji, 0,8-1,2 mas.% hitozana v 0,81,2 % raztopini mlečne kisline.Typical but non-limiting examples of tampons of the invention are tampons having an absorbent component or a tampon. a layer made of starting material for the manufacture of tampons in the form of 20-25 cm long and 4-6 cm wide viscous tampon tape with a viscous fiber mass of 2-4 g, to which was applied prior to entering the tampon making machine with a spray technique of 0, 2-0.5 g of formulation containing, calculated on the final concentration in the formulation, 0.8-1.2% by weight of chitosan in 0.81.2% lactic acid solution.
Še posebno je primeren nanos formulacije na tamponski viskozni trak v količini 0,080,2 g formulacije na 1 g viskoznih vlaken.Particularly suitable is the application of the formulation to a tampon viscose tape in an amount of 0.080.2 g formulation per 1 g of viscose fibers.
Uporaba formulacije v smislu izuma na osnovi hitozana in/ali hitozanskih materialov in organskih kislin ali njihovih derivatov, še zlasti mlečne kisline, je ugodna tudi iz ekonomskega vidika, saj so učinkovine relativno poceni, tako da njihova uporaba v tamponih nima znatnega vpliva na ceno končnega izdelka. Zaradi tega so novi tamponi v smislu izuma s cenovnega vidika zelo dostopni uporabnicam.The use of the formulation of the invention based on chitosan and / or chitosan materials and organic acids or their derivatives, especially lactic acid, is also economically advantageous, since the active ingredients are relatively cheap, so their use in tampons does not have a significant impact on the price of the final product. This makes the new tampons of the invention very affordable for users.
Iz rezultatov dosedanji analiz in testiranj, navedenih tu v nadaljevanju, sklepamo, da so tamponi v smislu izuma, ki vsebujejo vhodni material obdelan s formulacijo v smislu izuma, ob uporabi v vagini učinkoviti pri preprečevanju tako nastankov, kot tudi ponovitev glivičnih in bakterijskih vnetij vagine. Zaradi svojih lastnosti so lahko primerni za pogosto uporabo in sicer ne le v času menstruacije, ampak tudi izven tega časa. Zaradi antibakterijskega in antimikotičnega delovanja v njih prisotnih učinkovin so lahko uporabni kot sredstvo za preventivno in/ali kurativno zdravljenje v ginekologiji (npr. kot preventivno sredstvo pred vnetji, belim tokom itd.).From the results of the analyzes and tests presented hereinafter, we conclude that tampons of the invention containing the starting material treated with the formulation of the invention, when used in the vagina, are effective in preventing both the formation and recurrence of fungal and bacterial inflammation of the vagina . Due to their properties, they can be used frequently, not only during menstruation but also beyond that period. Due to the antibacterial and antimycotic action of the active ingredients, they can be used as a means of preventive and / or curative treatment in gynecology (eg as a preventative agent against inflammation, white flow, etc.).
Na podlagi dosedanjih testiranj tudi menimo, da bi z uporabo tamponov v smislu izuma oz. s preprečevanjem okužb vagine lahko posledično zmanjšali tudi tveganje za vnetje mehurja, ki je pri starejših ženskah eden izmed glavnih dejavnikov za urinsko inkontinenco. Z uporabo tamponov nekoliko večjih dimenzij bi lahko še nekoliko komprimirali sečnico, tako da bi proti uhajanju vode delovali na dva načina, preventivno in kurativno.Based on the tests performed so far, we also believe that using tampons according to the invention or. by preventing vaginal infections, the risk of bladder inflammation, which is one of the main factors for urinary incontinence in older women, can also be reduced. By using tampons of slightly larger dimensions, the urethra could be further compressed, so that there would be two ways of preventing water leakage, preventive and curative.
Izvedbeni primeri, ki so navedeni v nadaljevanju, so namenjeni zgolj za ponazoritev predloženega izuma in nikakor ne omejujejo njegovega obsega.The following examples are intended only to illustrate the present invention and do not in any way limit its scope.
Izvedbeni primeriImplementation examples
Priprava raztopine hitozana v mlečni kislini izdelava tamponov, ki vsebujejo to raztopinoPreparation of a solution of chitosan in lactic acid production of tampons containing this solution
Primer 1 g hitozana (hitozan z nizko povprečno molekulsko maso, firma Aldrich) smo raztopili v 500 ml vode ob postopnem dodajanju 5 % mlečne kisline (80 ml) in segrevanju na 40 °C, tako da smo dobili pH v območju med 3,6 in 3,8. Končna dejanska koncentracija hitozana v raztopini je 0,86 % in končna dejanska koncentracija mlečne kisline je 0,8 mas. %. Viskoznost raztopine je znašala 653 mPa.s pri 25°C.Example 1 g of chitosan (low average molecular weight chitosan, Aldrich company) was dissolved in 500 ml of water with the gradual addition of 5% lactic acid (80 ml) and heated to 40 ° C to give a pH in the range of 3.6 and 3.8. The final actual concentration of chitosan in solution is 0.86% and the final actual lactic acid concentration is 0.8 wt. %. The viscosity of the solution was 653 mPa.s at 25 ° C.
Pripravljeno raztopino smo ročno napršili na vhodni material za izdelavo tampone, ki je v obliki predhodno izdelanega viskoznega tamponskega traku širine 5 cm, v količini, ki ustreza 0,3-0,5 g raztopine na 2,5 g viskoznih vlaken (2,5 g viskoznih vlaken ustreza masi viskoznih vlaken, potrebnih za izdelavo enega tampona). Po postopku, ki je znan v stroki, smo iz z raztopino obdelanega tamponskega traku na stroju za izdelavo tamponov izdelali tampone.The prepared solution was manually sprayed onto the starting material for the manufacture of a tampon, which is in the form of a pre-fabricated 5 cm viscous buffer strip, in an amount corresponding to 0.3-0.5 g of the solution per 2.5 g of viscous fibers (2.5 g of viscose fibers corresponds to the mass of viscous fibers required to produce one tampon). According to a method known in the art, tampons were made from a solution of treated buffer tape on a tampon machine.
Analiza tamponov, ki raztopino hitozana v mlečni kislini po primeru 1Analysis of tampons making chitosan solution in lactic acid according to Example 1
1. Mehanske lastnosti1. Mechanical properties
Tamponom, katerih vhodni viskozni material je bil napršen z raztopino hitozana v mlečni kislini, kot je navedeno v primeru 1, in referenčnim tamponom, izdelanim iz vhodnega viskoznega materiala, smo v skladu standardnimi metodami, veljavnimi v stroki, določili ustrezne tehnološke parametre.Tampons whose starting viscous material was sprayed with a solution of chitosan in lactic acid as indicated in Example 1 and a reference tampon made from a starting viscous material were determined in accordance with the standard methods applicable in the art, appropriate technological parameters were determined.
Tabela 1: Mehanske lastnosti / tehnološki parametri tamponov, ki vsebujejo raztopino hitozana v mlečni kislini, po primeru 1 in referenčnih tamponov.Table 1: Mechanical properties / technological parameters of tampons containing a solution of chitosan in lactic acid according to Example 1 and reference tampons.
Tehnološki parametri tamponov, pripravljenih kot je navedeno v primeru 1, so v območju v stroki določenih proizvodnih standardov.The technological parameters of the tampons prepared as indicated in Example 1 are within the range of specific production standards.
2. Določitev kemijskih lastnosti: pH vrednost tamponov in vsebnost dušika v tamponih pH vrednost tamponov smo analizirali tako, da smo merili pH vrednosti destilirane vode (50 ml) v katero smo predhodno potopili tampone. Rezultati meritev so podani v tabeli 2.2. Determination of chemical properties: The pH value of the tampons and the nitrogen content of the tampons were analyzed by measuring the pH of the distilled water (50 ml) into which the tampons had previously been immersed. The results of the measurements are given in Table 2.
Tabela 2: pH vrednost destilirane vode, v katero so bili potopljeni tamponiTable 2: pH value of the distilled water into which the tampons were immersed
Iz rezultatov izhaja, da tamponi, pripravljeni kot je navedeno v primeru 1, učinkovito znižujejo pH v destilirani vodi, kar kaže na potencialno zniževanje pH oz vzdrževanje pH na fiziološkem pH v vagini.The results show that the tampons prepared as in Example 1 effectively lower the pH in distilled water, suggesting a potential decrease in pH or maintaining the pH at physiological pH in the vagina.
Tamponom, pri katerih smo vhodni material napršili z raztopino hitozana v mlečni kislini po primeru 1, smo določili vsebnost celokupnega dušika po Kjeldahl metodi (SIST EN 25663), na podlagi česar lahko spremljamo kvalitativno vezavo hitozana na tampone. Rezultati vsebnosti dušika v tamponih, pripravljenih kot je navedeno v primeru 1, in v referenčnih tamponih so podani v tabeli 3.Tampons sprayed with starting material with a solution of chitosan in lactic acid according to Example 1 determined the total nitrogen content by the Kjeldahl method (SIST EN 25663), on the basis of which the qualitative binding of chitosan to tampons can be monitored. The results of the nitrogen content of the tampons prepared as in Example 1 and of the reference tampons are given in Table 3.
Tabela 3: Koncentracija celokupnega dušika ( %)Table 3: Total nitrogen concentration (%)
Dani rezultati potijujejo, da je na modificiranih tamponih prisoten hitozan.The results show that chitosan is present on modified tampons.
3. Spektrofotometrična določitev vsebnosti hitozana v tamponih, izdelanih po primeru 13. Spectrophotometric determination of the chitosan content of the tampons made according to Example 1
S spektrofotometično metodo, ki temelji na principu vezave sulfonskega barvila na hitozan, smo izmerili, da ima tampon, izdelan kot je navedeno v primeru 1, vsebnost hitozana 3,3 mmol/kg. Izmeijena vsebnost hitozana v referenčnem tamponu je 0 mmol/kg.Using a spectrophotometric method based on the principle of coupling sulfone dye to chitosan, it was measured that the buffer made as in Example 1 had a chitosan content of 3.3 mmol / kg. The modified chitosan content of the reference buffer is 0 mmol / kg.
4. Antibakterijske in antimikotične lastnosti tamponov, izdelanih po primeru 14. Antibacterial and antifungal properties of tampons made according to Example 1
Rezultati testov na antibakterijske lastnosti in antimikotične lastnosti (po ASTMTest results for antibacterial and antimycotic properties (according to ASTM
E2149-01) tamponov, ki vsebujejo raztopino hitozana v mlečni kislini po primeru 1, so pokazali, da viskozni tamponi, ki vsebujejo raztopino po primeru 1, reducirajo bakterije Staphylococcus aureus za 97 %, Streptococcus. Agal za 100 %, MRSA za 91 % ter glivice rodu Candida za 68 %.E2149-01) Tampons containing a solution of chitosan in lactic acid according to Example 1 showed that viscous tampons containing a solution of Example 1 reduced Staphylococcus aureus by 97%, Streptococcus. Agal by 100%, MRSA by 91% and Candida by 68%.
Na osnovi dosedanjih testiranj in analiz sklepamo, da ima tampon z dodatkom formulacije v smislu izuma ob uporabi v vagini, ob sproščanju v njem prisotnih učinkovin, naslednje napredne in nove lastnosti: vzdržuje fiziološki pH vagine, vzdržuje ustrezno vlažnost vagine in ima antimikotično in antibakterijsko aktivnost.Based on the tests and analyzes carried out so far, it is concluded that the tampon with the addition of the formulation of the invention, when used in the vagina, with the release of active ingredients, has the following advanced and novel properties: maintains the physiological pH of the vagina, maintains adequate vaginal humidity and has antifungal and antibacterial activity .
Claims (28)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200600138A SI22285A (en) | 2006-06-05 | 2006-06-05 | Tampon containing ph-regulating and antibacterially and antimicotically active formulation, and procedure of its manufacture |
| PCT/SI2007/000009 WO2007142609A2 (en) | 2006-06-05 | 2007-03-09 | Tampon which contains ph regulating, antibacterial, and antimycotic active formulation and the procedure of its production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200600138A SI22285A (en) | 2006-06-05 | 2006-06-05 | Tampon containing ph-regulating and antibacterially and antimicotically active formulation, and procedure of its manufacture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI22285A true SI22285A (en) | 2007-12-31 |
Family
ID=38658445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200600138A SI22285A (en) | 2006-06-05 | 2006-06-05 | Tampon containing ph-regulating and antibacterially and antimicotically active formulation, and procedure of its manufacture |
Country Status (2)
| Country | Link |
|---|---|
| SI (1) | SI22285A (en) |
| WO (1) | WO2007142609A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010021930A1 (en) * | 2008-08-16 | 2010-02-25 | Synedgen, Inc. | Prevention and treatment of mrsa infections with chitosan-derivatives |
| JP2013519807A (en) * | 2010-02-16 | 2013-05-30 | プレイテックス プロダクツ エルエルシー | Fiber having low pH, optimum ORP, reduced odor, method for producing the fiber, and article produced therefrom |
| US9034593B2 (en) | 2010-11-22 | 2015-05-19 | Kimberly-Clark Worldwide, Inc. | Vaginal indicator to detect biomarkers of good health |
| US11304894B2 (en) | 2020-05-04 | 2022-04-19 | Garrett E. Wdowin | Compositions, delivery devices, and methods thereof for feminine health |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL138183A0 (en) * | 2000-08-31 | 2001-10-31 | Rostam Ltd | Ph reducing formulation and delivery system for a tampon |
| US7217804B2 (en) * | 2001-04-24 | 2007-05-15 | The Procter & Gamble Company | Articles comprising cationic polysaccharides and acidic pH buffering means |
| EP1287836B1 (en) * | 2001-08-24 | 2009-02-18 | The Procter & Gamble Company | Absorbent member with improved fluid handling agent |
| JP2008517143A (en) * | 2004-10-18 | 2008-05-22 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | Method for producing antimicrobial polymer articles |
-
2006
- 2006-06-05 SI SI200600138A patent/SI22285A/en not_active IP Right Cessation
-
2007
- 2007-03-09 WO PCT/SI2007/000009 patent/WO2007142609A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007142609A2 (en) | 2007-12-13 |
| WO2007142609A3 (en) | 2008-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101417557B1 (en) | Low ph, optimal orp, and odor-reducing fibers, a process for making the fibers, and articles made therefrom | |
| US7863264B2 (en) | Stabilised compositions having antibacterial activity | |
| DE102006001954B4 (en) | Antiseptic alginate preparation, process for their preparation, and their use | |
| DE69018684T2 (en) | Antimicrobial plastic materials with broadband effect. | |
| US20130217649A1 (en) | Silver containing wound dressing | |
| CN105311669B (en) | Bacteria-inhibiting type sanitary napkin | |
| CN111705508A (en) | A kind of antibacterial coconut fiber for sanitary napkin and preparation method and application thereof | |
| CN109498834B (en) | Antibacterial hydrocolloid dressing and preparation method thereof | |
| SI22285A (en) | Tampon containing ph-regulating and antibacterially and antimicotically active formulation, and procedure of its manufacture | |
| WO2020016758A1 (en) | Nitric oxide producing collagen/orc dressing | |
| CN111012585A (en) | Weakly acidic antibacterial absorbing article and preparation method thereof | |
| Fras Zemljic et al. | Viscose material functionalized by chitosan as a potential treatment in gynecology | |
| JP2010531210A (en) | Articles containing calcium for reducing TSST-1 production | |
| JP4370097B2 (en) | Antibacterial diapers and wet wipes | |
| CN103407205B (en) | Konjac glucomannan fiber wet tissue and method for preparing same | |
| CN106512063A (en) | Preparing method of silver-containing anti-bacterial dressing | |
| CN108619550A (en) | A kind of hydrogel and preparation method thereof | |
| CN112773737A (en) | Skin-care and bacteriostatic coconut fat solvent and preparation method and application thereof | |
| CA2692094C (en) | Antimicrobial compositions | |
| CN114524969B (en) | A kind of N halide type antibacterial gelatin sponge and its preparation method and application | |
| CN101637421A (en) | Active oxygen slow-release sanitary towel and active oxygen slow-release agent | |
| KR20160006448A (en) | Method for preparing multipurpose antibacterial sponge and the sponge made therefrom | |
| US20220117714A1 (en) | Biodegradable wrap for veterinary use, especially leg wraps for cattle | |
| CN119656360B (en) | A highly soft and skin-friendly sanitary napkin and its preparation method | |
| CN115569109B (en) | A sustained-release gynecological antibacterial gel and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OO00 | Grant of patent |
Effective date: 20061002 |
|
| KO00 | Lapse of patent |
Effective date: 20160609 |